BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 15196531)

  • 1. Expression of HER2 and its association with AP-2 in breast cancer.
    Pellikainen J; Naukkarinen A; Ropponen K; Rummukainen J; Kataja V; Kellokoski J; Eskelinen M; Kosma VM
    Eur J Cancer; 2004 Jul; 40(10):1485-95. PubMed ID: 15196531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HER2 overexpression correlates with survival after curative resection of pancreatic cancer.
    Komoto M; Nakata B; Amano R; Yamada N; Yashiro M; Ohira M; Wakasa K; Hirakawa K
    Cancer Sci; 2009 Jul; 100(7):1243-7. PubMed ID: 19432892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endosomal protein expression of γ1-adaptin is associated with tumor growth activity and relapse-free survival in breast cancer.
    Hoshi N; Uemura T; Tachibana K; Abe S; Murakami-Nishimagi Y; Okano M; Noda M; Saito K; Kono K; Ohtake T; Waguri S
    Breast Cancer; 2024 Mar; 31(2):305-316. PubMed ID: 38265632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ZIP Code to Genomic Code: Neighborhood Disadvantage, Aggressive Breast Cancer Biology, and Breast Cancer Outcomes.
    Goel N; Hernandez AE; Antoni MH; Kesmodel S; Pinheiro PS; Kobetz E; Merchant N; Cole SW
    Ann Surg; 2024 Jul; 280(1):1-10. PubMed ID: 38545788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SLC35A2 expression is associated with HER2 expression in breast cancer.
    Wang Y; Peng X; Wu M; Wang B; Chen T; Zhan X
    Discov Oncol; 2024 Apr; 15(1):124. PubMed ID: 38639872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusion.
    Fraune C; Harms L; Büscheck F; Höflmayer D; Tsourlakis MC; Clauditz TS; Simon R; Möller K; Luebke AM; Möller-Koop C; Steurer S; Hube-Magg C; Sauter G; Weidemann S; Lebok P; Dum D; Kind S; Minner S; Izbicki JR; Schlomm T; Huland H; Heinzer H; Burandt E; Haese A; Graefen M; Schroeder C
    Mol Med; 2020 Mar; 26(1):24. PubMed ID: 32143573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The biological characteristics of transcription factors AP-2α and AP-2γ and their importance in various types of cancers.
    Kołat D; Kałuzińska Ż; Bednarek AK; Płuciennik E
    Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30824562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA Sequencing Uncovers Molecular Mechanisms Underlying Pathological Complete Response to Chemotherapy in Patients with Operable Breast Cancer.
    Li Y; Liu X; Tang H; Yang H; Meng X
    Med Sci Monit; 2017 Sep; 23():4321-4327. PubMed ID: 28880852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TFAP2A is a component of the ZEB1/2 network that regulates TGFB1-induced epithelial to mesenchymal transition.
    Dimitrova Y; Gruber AJ; Mittal N; Ghosh S; Dimitriades B; Mathow D; Grandy WA; Christofori G; Zavolan M
    Biol Direct; 2017 Apr; 12(1):8. PubMed ID: 28412966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of Tcfap2c in tumorigenesis and cancer growth in an activated Neu model of mammary carcinogenesis.
    Park JM; Wu T; Cyr AR; Woodfield GW; De Andrade JP; Spanheimer PM; Li T; Sugg SL; Lal G; Domann FE; Zhang W; Weigel RJ
    Oncogene; 2015 Dec; 34(50):6105-14. PubMed ID: 25772240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salivary expression of soluble HER2 in breast cancer patients with positive and negative HER2 status.
    Laidi F; Bouziane A; Lakhdar A; Khabouze S; Rhrab B; Zaoui F
    Onco Targets Ther; 2014; 7():1285-9. PubMed ID: 25053886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sumoylation pathway is required to maintain the basal breast cancer subtype.
    Bogachek MV; Chen Y; Kulak MV; Woodfield GW; Cyr AR; Park JM; Spanheimer PM; Li Y; Li T; Weigel RJ
    Cancer Cell; 2014 Jun; 25(6):748-61. PubMed ID: 24835590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional regulation of the GPX1 gene by TFAP2C and aberrant CpG methylation in human breast cancer.
    Kulak MV; Cyr AR; Woodfield GW; Bogachek M; Spanheimer PM; Li T; Price DH; Domann FE; Weigel RJ
    Oncogene; 2013 Aug; 32(34):4043-51. PubMed ID: 22964634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of transcription factor TFAP2α correlates with chemosensitivity in advanced bladder cancer.
    Nordentoft I; Dyrskjøt L; Bødker JS; Wild PJ; Hartmann A; Bertz S; Lehmann J; Orntoft TF; Birkenkamp-Demtroder K
    BMC Cancer; 2011 Apr; 11():135. PubMed ID: 21489314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative TFAP2A isoforms have distinct activities in breast cancer.
    Berlato C; Chan KV; Price AM; Canosa M; Scibetta AG; Hurst HC
    Breast Cancer Res; 2011 Mar; 13(2):R23. PubMed ID: 21375726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of primary gene targets of TFAP2C in hormone responsive breast carcinoma cells.
    Woodfield GW; Chen Y; Bair TB; Domann FE; Weigel RJ
    Genes Chromosomes Cancer; 2010 Oct; 49(10):948-62. PubMed ID: 20629094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-beta inactivation and TGF-alpha overexpression cooperate in an in vivo mouse model to induce hepatocellular carcinoma that recapitulates molecular features of human liver cancer.
    Baek JY; Morris SM; Campbell J; Fausto N; Yeh MM; Grady WM
    Int J Cancer; 2010 Sep; 127(5):1060-71. PubMed ID: 20020490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. n-Butylidenephthalide induced apoptosis in the A549 human lung adenocarcinoma cell line by coupled down-regulation of AP-2alpha and telomerase activity.
    Wei CW; Lin CC; Yu YL; Lin CY; Lin PC; Wu MT; Chen CJ; Chang W; Lin SZ; Chen YL; Harn HJ
    Acta Pharmacol Sin; 2009 Sep; 30(9):1297-306. PubMed ID: 19701232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin inhibits ErbB2 to induce apoptosis in cervical cancer cells.
    Xiang S; Sun Z; He Q; Yan F; Wang Y; Zhang J
    Med Oncol; 2010 Jun; 27(2):379-87. PubMed ID: 19424877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combined immunodetection of AP-2alpha and YY1 transcription factors is associated with ERBB2 gene overexpression in primary breast tumors.
    Allouche A; Nolens G; Tancredi A; Delacroix L; Mardaga J; Fridman V; Winkler R; Boniver J; Delvenne P; Begon DY
    Breast Cancer Res; 2008; 10(1):R9. PubMed ID: 18218085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.